Treatment for primary postpartum haemorrhage

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 9, 2014, Pages

  Mousa, Hatem A ^a   Blum, Jennifer ^b   Abou El Senoun, Ghada ^c   Shakur, Haleema ^d   Alfirevic, Zarko ^e  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b GYNUITY HEALTH PROJECTS   (United States)

^c QUEEN S MEDICAL CENTRE   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ERGOMETRINE PLUS OXYTOCIN; ESTRADIOL BENZOATE; MISOPROSTOL; OXYTOCIN; PLACEBO; TRANEXAMIC ACID; UTEROTONIC AGENT; ERGOMETRINE; OXYTOCIC AGENT;

BLOOD TRANSFUSION; COMPRESSION THERAPY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYSTERECTOMY; INTENSIVE CARE; MATERNAL MORBIDITY; MATERNAL MORTALITY; NAUSEA; POSTPARTUM HEMORRHAGE; PRIMARY POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; REVIEW; SHIVERING; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VOMITING; FEMALE; META ANALYSIS; PREGNANCY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTAL DRUG ADMINISTRATION;

ADMINISTRATION, RECTAL; ERGONOVINE; FEMALE; HUMANS; HYSTERECTOMY; MATERNAL MORTALITY; MISOPROSTOL; OXYTOCICS; OXYTOCIN; POSTPARTUM HEMORRHAGE; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84898844242     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003249.pub3     Document Type: Review

References (154)

1. Blum J, Winikoff B, Raghavan S, Dabash R, Ramadan MC, Dilbaz B, et al. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial. Lancet 2010;375(9710):217-23. 3353804
2. Blum J, Winikoff B, Raghavan S, Dabash R, Ramadan MC, Dilbaz B, et al. Treatment of postpartum hemorrhage with sublingual misoprostol versus oxytocin: results from a randomized noninferiority trial among women receiving prophylactic oxytocin. International Journal of Gynecology & Obstetrics 2009;107(Suppl 2):S22-S23. 3353805
3. Dao B, Blum J, Barrera G, Cherine Ramadan M, Dabash R, Darwish E, et al. Side effect profiles for misoprostol and oxytocin in the treatment of postpartum hemorrhage. International Journal of Gynecology & Obstetrics 2009;107(Suppl 2):S150. 3353806
4. Chantrapitak W, Srijanteok K, Puangsa-art S. Lower uterine segment compression for management of early postpartum hemorrhage after vaginal delivery at Charoenkrung Pracharak Hospital. Journal of the Medical Association of Thailand 2009;92(5):600-5. 3353808
5. Ducloy-Bouthers A, Broisin F, Keita H, Fontaine S, Depret S, Legoeff F, et al. Tranexamic acid reduces blood loss in postpartum haemorrhage. Critical Care 2010;14()(Suppl 1):S124. 3353810
6. Ducloy-Bouthors AS, Duhamel A, Broisin F, Keita H, Fontaine S. Tranexamic acid reduces blood loss in post-partum haemorrhage by reducing hyperfibrinolysis. British Journal of Anaesthesia 2012;108:ii191. 3353811
7. Ducloy-Bouthors AS, Duhamel A, Tournoys A, Prado-Dupont A, Debize G, Peneau E, et al. Post-partum haemorrhage induced hyperfibrinolysis. Thrombosis Research 2013;131(Suppl 1):S89-90. 3353812
8. Ducloy-Bouthors AS, Jude B, Duhamel A, Broisin F, Huissoud C, Keita-Meyer H, et al. High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Critical Care (London, England) 2011;15(2):R117. 3353813
9. Hofmeyr GJ, Ferreira S, Nikodem VC, Mangesi L, Singata M, Jafta Z, et al. Misoprostol for treating postpartum haemorrhage: a randomized controlled trial [ISRCTN72263357]. BMC Pregnancy and Childbirth 2004;4(1):16. 3353815
10. Maholwana B, Hofmeyr GJ, Nikodem C, Ferreira S, Singata M, Mangesi L, et al. Misoprostol for treating postpartum haemorrhage. Presented at: 21st Conference on Priorities in Perinatal Care in South Africa. 2002 March 5-8; Eastern Cape, South Africa. 3353816
11. Lokugamage AU, Moodley J, Sullivan K, Rodeck CH, Niculescu L, Tigere P. The Durban primary postpartum haemorrhage study. Women's Health - into the new millennium. Proceedings of the 4th International Scientific Meeting of the Royal College of Obstetricians and Gynaecologists; 1999 October 3-6; Cape Town, South Africa. 1999:77-8. 3353818
12. Lokugamage AU, Sullivan KR, Niculescu I, Tigere P, Onyangunga F, El Refaey H, et al. A randomized study comparing rectally administered misoprostol versus syntometrine combined with an oxytocin infusion for the cessation of primary post partum hemorrhage. Acta Obstetricia et Gynecologica Scandinavica 2001;80(9):835-9. 3353819
13. Walraven G, Dampha Y, Bittaye B, Sowe M, Hofmeyr J. Misoprostol in the treatment of postpartum haemorrhage in addition to routine management: a placebo randomised control trial. BJOG: an international journal of obstetrics and gynaecology 2004;111:1014-7. 3353821
14. Villar J. Misoprostol to treat postpartum hemorrhage (PPH): a randomized controlled trial (Argentina, Egypt, South Africa, Thailand and Viet Nam). Current Controlled Trials (www.controlled-trials.com/mrct) (accessed 21 March 2006). 3353823
15. Widmer M, Blum J, Hofmeyr GJ, Carroli G, Abdel-Aleem H, Lumbiganon P, et al. Misoprostol as an adjunct to standard uterotonics for treatment of post-partum haemorrhage: a multicentre, double-blind randomised trial. Lancet 2010;375(9728):1808-13. 3353824
16. Winikoff B. Misoprostol for the treatment of postpartum hemorrhage. ClinicalTrials.gov (http://clinicaltrials.gov/) (accessed 20 February 2008). 3353828
17. Winikoff B, Dabash R, Durocher J, Darwish E, Ngoc NTN, Leon W, et al. Treatment of postpartum hemorrhage with sublingual misoprostol versus oxytocin: results from a randomized, non-inferiority trial among women not exposed to oxytocin during labor. International Journal of Gynecology & Obstetrics 2009;107(Suppl 2):S59. 3353826
18. Winikoff B, Dabash R, Durocher J, Darwish E, Nguyen TN, Leon W, et al. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial. Lancet 2010;375(9710):210-6. 3353827
19. Zhou M, Yang CY, Zhao Y, Li P. Clinical value of adjuvant therapy with estrogen for postpartum hemorrhage. Journal of Southern Medical University 2006;26(6):865-6. 3353830
20. Zuberi NF, Durocher J, Sikander R, Baber N, Blum J, Walraven G. Misoprostol in addition to routine treatment of postpartum hemorrhage: a hospital-based randomized-controlled trial in Karachi, Pakistan. BMC Pregnancy and Childbirth 2008;8:40. 3353832
21. Deneux-Tharaux C, Dupont C, Colin C, Rabilloud M, Touzet S, Lansac J, et al. Multifaceted intervention to decrease the rate of severe postpartum haemorrhage: the PITHAGORE6 cluster-randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology 2010;117(10):1278-87. 3353834
22. Khalil MI, Al-Dohami H, Aldahish MM. A method to improve the effectiveness of the Bakri balloon for management of postpartum haemorrhage at caesarean. International Journal of Gynaecology and Obstetrics 2011;115(2):198-200. 3353836
23. Khireddine I, Le C, Dupont C, Rudigoz R, Bouvier-Colle M, Deneux-Tharaux C. Induction of labor and risk of postpartum hemorrhage in low risk parturient women. Journal of Maternal-Fetal and Neonatal Medicine 2012;25(S2):101. 3353838
24. Magwali TL, Butrick E, Mambo V, El Ayadi A, Lippman S, Bergel E, et al. Non-pneumatic anti-shock garment (NASG) for obstetric hemorrhage:Harare, Zimbabwe. International Journal of Gynecology & Obstetrics 2012;119(Suppl 3):S410. 3353840
25. Soltan MH, Faragallah MF, Mosabah MH, Al-Adawy AR. External aortic compression device: the first aid for postpartum hemorrhage control. Journal of Obstetrics and Gynaecology Research 2009;35(3):453-8. 3353842
26. Soltan MH, Imam HH, Zahran KA, Atallah SM. Assessing changes in flow velocimetry and clinical outcome following use of an external aortic compression device in women with postpartum hemorrhage. International Journal of Gynecology & Obstetrics 2010;110(3):257-61. 3353844
27. Takagi S, Yoshida T, Togo Y, Tochigi H, Abe M, Sakata H, et al. The effects of intramyometrial injection of prostaglandin F2alpha on severe post-partum hemorrhage. Prostaglandins 1976;12(4):565-79. 3353846
28. Gris JC. rhuFVIIa in post-partum hemorrhage. ClinicalTrials.gov (http://clinicaltrials.gov/) (accessed 20 February 2008). 3353848
29. Lavigne-Lissalde G, Aya G, Mercier F, Roger-Christophe S, Chauleur C, Morau E, et al. rhuFVIIa in women with a refractory primary postpartum haemorrhage: an international, multicenter, randomised, opened, controlled trial. Thrombosis Research 2013;131(Suppl 1):S74. 3353849
30. Collins P. Fibrinogen concentrate versus placebo for treatment of postpartum haemorrhage: A multicentre, prospective, double blind randomised control trial. ClinicalTrials.gov (http://clinicaltrials.gov/) (accessed 2013). 3353851
31. Miller S. Non-pneumatic anti-shock garment for obstetrical hemorrhage: Zambia and Zimbabwe. ClinicalTrials.gov (http://clinicaltrials.gov/) (accessed 20 February 2008). 3353853
32. Mirzazada S. Misoprostol for the treatment of postpartum haemorrhage (PPH) following self-administration of misoprostol prophylaxis in home deliveries. ClinicalTrials.gov (accessed 21 May 2013). 3353855
33. Gulmezoglu M, Alfirevic Z, Elbourne D, Roberts I. Tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind, placebo controlled trial (woman trial - Protocol Number ISRCTN76912190). International Journal of Gynecology & Obstetrics 2009;107(Suppl 2):S500. 3353857
34. Shakur H, Elbourne D, Gulmezoglu M, Alfirevic Z, Ronsmans C, Allen E, et al. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials 2010;11:40. 3353858
35. Wikkelsoe AJ, Afshari A, Stensballe J, Langhoff-Roos J, Albrechtsen C, Ekelund K, et al. The FIB-PPH trial: fibrinogen concentrate as initial treatment for postpartum haemorrhage: study protocol for a randomised controlled trial. Trials [Electronic Resource] 2012;13:110. 3353860
36. Abdel-Aleem H, El-Nashar I, Abdel-Aleem A. Management of severe postpartum hemorrhage with misoprostol. International Journal of Gynecology & Obstetrics. 2001;72:75-6.
37. Abdel-Aleem H, Villar J, Gulmezoglu AM, Mostafa SA, Youssef AA, Shokry M, et al. The pharmacokinetics of the prostaglandin E1 analogue misoprostol in plasma and colostrum after postpartum oral administration. European Journal of Obstetrics & Gynecology and Reproductive Biology 2003;108:25-8.
38. AbdRabbo SA. Stepwise uterine devascularization: a novel technique for the management of uncontrollable postpartum hemorrhage with preservation of the uterus. American Journal of Obstetrics and Gynecology 1994;171:694-700.
39. Abou El Senoun G, Singh M, Mousa HA, Alfirevic Z. Update on the new modalities on the prevention and management of postpartum haemorrhage. Fetal and Maternal Medicine Review 2011;22(4):247-64.
40. Abou Zahr C, Royston E. Global Mortality: Global Factbook. Geneva: World Health Organization, 1991.
41. ACOG Technical Bulletin. American College of Obstetricians and Gynecologists educational bulletin. Postpartum hemorrhage, Number 243. International Journal of Gynecology & Obstetrics 1998;61(1):79-86.
42. Adekanmi OA, Purmessur S, Edwards G, Barrington JW. Intrauterine misoprostol for the treatment of severe recurrent atonic secondary postpartum haemorrhage. BJOG: an international journal of obstetrics and gynaecology 2001;108:541-2.
43. Aisaka K, Ando S, Kokuho K, Tawada T, Kaneda S, Yoshimatsu J, et al. Effects of obesity and weight gain during pregnancy on obstetrical factors. Acta Obstetrica et Gynaecologica Japonica 1988;63:1851-8.
44. Akhter S, Begum MR, Kabir J. Condom hydrostatic tamponade for massive postpartum hemorrhage. International Journal of Gynecology & Obstetrics 2005;90:134-5.
45. Alamia V Jr, Meyer BA. Peripartum hemorrhage. Obstetrics and Gynecology Clinics of North America 1999;26(2):385-98.
46. Alexander J, Thomas P, Sanghera J. Treatments for secondary postpartum haemorrhage. Cochrane Database of Systematic Reviews 2002, Issue 1. [DOI: 10.1002/14651858.CD002867]
47. Alfirevic Z, Weeks A. Oral misoprostol for induction of labour. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD001338.pub2]
48. Alfirevic Z, Elbourne D, Pavord S, Bolte A, Van Geijn H, Mercier F, et al. Use of recombinant activated factorVII in primary postpartum hemorrhage: the Northern European registry 2000-2004. Obstetrics and Gynecology 2007;110(6):1270-8.
49. Andolina KL, Tolosa JE, Monzo JM, Roberts NS, Daly S. Oral misoprostol is rapidly absorbed in postpartum women at term. Journal of Maternal-Fetal & Neonatal Medicine 2003;14:229-32.
50. Arulkumaran S, Walker JJ, Watkinson AF, Nicholson T, Kessel D, Patel J. The Role of Emergency and Elective Interventional Radiology in Postpartum Haemorrhage: Good Practice No 6. London: RCOG, 2007.
51. As AK, Hagen P, Webb JB. Tranexamic acid in the management of postpartum haemorrhage. British Journal of Obstetrics and Gynaecology 1996;103(12):1250-1.
52. B-Lynch C, Coker A, Lawal AH, Abu J, Cowen MJ. The B-Lynch surgical technique for the control of massive postpartum haemorrhage: an alternative to hysterectomy? Five cases reported. British Journal of Obstetrics and Gynaecology 1997;104(3):372-5.
53. Bakri YN. Balloon device for control of obstetrical bleeding. European Journal of Obstetrics & Gynecology, and Reproductive Biology 1999;86:S84.
54. Baskett TF. A flux of the reds: evolution of active management of the third stage of labour. Journal of the Royal Society of Medicine 2000;93:489-93.
55. Begley CM, Gyte GML, Devane D, McGuire W, Weeks A. Active versus expectant management for women in the third stage of labour. Cochrane Database of Systematic Reviews 2011, Issue 11. [DOI: 10.1002/14651858.CD007412]
56. Beischer NA, Mackay EV. Obstetrics and the Newborn. Eastbourne: Bailliere Tindall, 1986.
57. Bergstrom S, Ryhag ER, Samuelson B, Sjovall J. The structure of prostaglandin E, F1, F2. Acta Chemica Scandinavica 1962;16:501-2.
58. Bonnar J. Massive obstetric haemorrhage. Baillieres Best Practice and Research in Clinical Obstetrics and Gynaecology 2000;14(1):1-18.
59. Burchell RC. Postpartum haemorrhage. In: Quilligan ES editor(s). Current Therapy in Obstetrics and Gynaecology. Philadelphia: WB Saunders, 1980.
60. Cantwell R, Clutton-Brock T, Cooper G, Dawson A, Drife J, Garrod D, et al. Saving Mothers" Lives: reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG: an international journal of obstetrics and gynaecology 2011;118(Suppl 1):1-203.
61. Carroli G, Cuesta C, Abalos E, Gulmezoglu AM. Epidemiology of postpartum hemorrhage: a systematic review. Best Practice and Research. Clinical Obstetrics and Gynaecology 2008;22(6):999-1020.
62. Chan C, Razvi K, Tham KF, Arulkumaran S. The use of a Sengstaken-Blakemore tube to control post-partum hemorrhage. International Journal of Gynaecology and Obstetrics 1997;58:251-2.
63. Cho JH, Jun HS, Lee CN. Hemostatic suturing technique for uterine bleeding during cesarean delivery. Obstetrics & Gynecology 2000;96(1):129-31.
64. Clark SL, Phelan JP, Yeh SY, Bruce SR, Paul RH. Hypogastric artery ligation for obstetric hemorrhage. Obstetrics & Gynecology 1985;66(3):353-6.
65. Combs CA, Murphy EL, Laros RK. Factors associated with postpartum haemorrhage with vaginal birth. Obstetrics & Gynecology 1991;77:69-76.
66. Cotter AM, Ness A, Tolosa JE. Prophylactic oxytocin for the third stage of labour. Cochrane Database of Systematic Reviews 2001, Issue 4. [DOI: 10.1002/14651858.CD001808]
67. CRASH-2 trial collaborators, Shakur H, Roberts I, Bautista R, Caballero J, Coats T, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010;376(9734):23-32.
68. Cunningham FG, MacDonald PC, Gant NF, Leveno KJ, Gilstrap LC. Abnormalities of the third stage of labor. Williams Obstetrics. 19th Edition. Norwalk, CT: Appleton & Lange, 1993.
69. Cutler BS, Daggett WM. Application of the "G-suit" to the control of hemorrhage in massive trauma. Annals of Surgery 1971;173(4):511-4.
70. Danielsson KG, Marions L, Rodriguez A, Spur BW, Wong PY, Bygdeman M. Comparison between oral and vaginal administration of misoprostol on uterine contractility. Obstetrics & Gynecology 1999;93:275-80.
71. Davis ME, Adher FL, Rogers G, Kharasch MS, Legault RR. A new active principle in ergot and its effects on uterine motility. American Journal of Obstetrics and Gynecology 1935;29:155-67.
72. De Loor JA, van Dam PA. Foley catheters for uncontrollable obstetric or gynecologic hemorrhage. Obstetrics & Gynecology 1996;88:737-8.
73. Dodd JM, Crowther CA. Misoprostol for induction of labour to terminate pregnancy in the second or third trimester for women with a fetal anomaly or after intrauterine fetal death. Cochrane Database of Systematic Reviews 2010, Issue 4. [DOI: 10.1002/14651858.CD004901.pub2]
74. Doumouchtsis SK, Papageorghiou AT, Arulkumaran S. Systematic review of conservative management of postpartum hemorrhage: what to do when medical treatment fails. Obstetrical and Gynecological Survey 2007;62(8):540-7.
75. Drife J. Management of primary postpartum haemorrhage. British Journal of Obstetrics and Gynaecology 1997;104:275-7.
76. Du Vigneaud V, Ressler C, Swan JM, Roberts CW, Katsoyannis PG, Gordon S. The synthesis of an octapeptide with the hormonal activity of oxytocin. Journal of the American Chemical Society 1953;75:4879-80.
77. Dudley HW, Moir C. The substance responsible for the traditional clinical effect of ergot. BMJ 1935;i:520-3.
78. Eastman NJ. Anomalies of the third stage of labor. William's Obstetrics. 10th Edition. New York: Appleton-Century-Crofts, 1950:917-9.
79. Ferrer P, Roberts I, Sydenham E, Blackhall K, Shakur H. Anti-fibrinolytic agents in post partum haemorrhage: a systematic review. BMC Pregnancy Childbirth 2009;15(9):29.
80. Franchini M, Franchi M, Bergamini V, Montagnana M, Salvagno GL, Targher G, et al. The use of recombinant activated FVII in postpartum haemorrhage. Clinical Obstetrics and Gynecology 2010;53:219-27.
81. Gando S, Iba T, Eguchi Y, Ohtomo Y, Okamoto K, Koseki K, et al. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Critical Care Medicine 2006;34(3):625-31.
82. Georgiou C. Balloon tamponade in the management of postpartum haemorrhage: a review. BJOG: an international journal of obstetrics and gynaecology 2009;116:748-57.
83. Gilbert L, Porter W, Brown VA. Postpartum haemorrhage: a continuing problem. British Journal of Obstetrics and Gynaecology 1987;94:67-71.
84. Gyte G. The significance of blood loss at delivery. MIDIRS Midwifery Digest 1992;2(1):88-92.
85. Gülmezoglu AM, Villar J, Ngoc NT, Piaggio G, Carroli G, Adetoro L, et al. WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet 2001;358(9283):689-95.
86. Haggerty J. Antishock garment. http://www.sti.nasa.gov/tto/spinoff1996/28. (accessed 20 February 2008).
87. Hall MH, Halliwell R, Carr-Hill R. Concomitant and repeated happenings of complications of the third stage of labour. British Journal of Obstetrics and Gynaecology 1985;92:732-8.
88. Hayman RG, Arulkumaran S, Steer PJ. Uterine compression sutures: surgical management of postpartum hemorrhage. Obstetrics & Gynecology 2002;99(3):502-6.
89. Hensleigh PA. Anti-shock garment provides resuscitation and haemostasis for obstetric haemorrhage. BJOG: an international journal of obstetrics and gynaecology 2002;109(12):1377-84.
90. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
91. Hofmeyr GJ, Walraven G, Gulmezoglu AM, Maholwana B, Alfirevic Z, Villar J. Misoprostol to treat postpartum haemorrhage: a systematic review. BJOG: an international journal of obstetrics and gynaecology 2005;112:547-53.
92. Hofmeyr GJ, Gülmezoglu AM. Misoprostol for the prevention and treatment of postpartum haemorrhage. Best Practice & Research Clinical Obstetrics & Gynaecology 2008;22(6):1025-41.
93. Hunter DJ, Schulz P, Wassenaar W. Effect of carbetocin, a long acting oxytocin analogue in the postpartum uterus. Clinical Pharmacology and Therapeutics 1992;52:60-7.
94. Johanson R, Kumar M, Obhrai M, Young P. Management of massive postpartum haemorrhage: use of a hydrostatic balloon catheter to avoid laparotomy. BJOG: an international journal of obstetrics and gynaecology 2001;108(4):420-2.
95. Jouppila P. Postpartum haemorrhage. Current Opinion in Obstetrics and Gynecology 1995;7:446-50.
96. Khan RU, El-Refaey H. Pharmacokinetics and adverse-effect profile of rectally administered misoprostol in the third stage of labour. Obstetrics & Gynecology 2003;101:968-74.
97. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006;367(9516):1066-74.
98. Knight M, Callaghan WM, Berg C, Alexander S, Bouvier-Colle MH, Ford JB, et al. Trends in postpartum haemorrhage in high resource countries: a review and recommendations from the International Postpartum Haemorrhage Collaborative Group. BMC Pregnancy Childbirth 2009;27(9):55.
99. Liabsuetrakul T, Choobun T, Peeyananjarassri K, Islam QM. Prophylactic use of ergot alkaloids in the third stage of labour. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD005456.pub2]
100. Maier RC. Control of postpartum haemorrhage with uterine packing. American Journal of Obstetrics and Gynecology 1993;169:317-23.
101. Marasinghe JP, Condous G, Seneviratne HR, Marasinghe U. Modified anchored B-Lynch uterine compression suture for post partum bleeding with uterine atony. Acta Obstetricia et Gynecologica Scandinavica 2011;90:280-3.
102. McDonald SJ, Abbott JM, Higgins SP. Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD000201]
103. McDonald SJ, Middleton P, Dowswell T, Morris PS. Effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes. Cochrane Database of Systematic Reviews 2013, Issue 7. [DOI: 10.1002/14651858.CD004074.pub3]
104. Miller S, Ojengbede O, Turan JM, Morhason-Bello IO, Martin HB, Nsima D. A comparative study of the non-pneumatic anti-shock garment for the treatment of obstetric hemorrhage in Nigeria. International Journal of Gynecology & Obstetrics 2009;107(2):121-5.
105. Miller S, Fathalla MM, Ojengbede OA, Camlin C, Mourad-Youssif M, Morhason-Bello IO, et al. Obstetric hemorrhage and shock management: using the low technology non-pneumatic anti-shock garment in Nigerian and Egyptian tertiary care facilities. BMC Pregnancy Childbirth 2010;18:10-64.
106. Mobeen N, Durocher J, Zuberi N, Jahan N, Blum J, Wasim S, et al. Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial. BJOG: an international journal of obstetrics and gynaecology 2011;118:353-61.
107. Moir JC. The action of ergot preparations on the puerperal uterus. BMJ 1935;i:520-3.
108. Moscardo F, Perez F, de la Rubia J, Balerdi B, Lorenzo JI, Senent ML, et al. Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. British Journal of Haematology 2001;114:174-6.
109. Mousa HA, Walkinshaw S. Major postpartum haemorrhage. Current Opinion in Obstetrics and Gynecology 2001;13(6):595-603.
110. Mousa H, Alfirevic Z. Major postpartum hemorrhage: survey of maternity units in the United Kingdom. Acta Obstetricia et Gynecologica Scandinavica 2002;81(8):727-30.
111. Mousa HA, Cording V, Alfirevic Z. Risk factors and interventions associated with major primary postpartum hemorrhage unresponsive to first-line conventional therapy. Acta Obstetricia et Gynecologica Scandinavica 2008;87(6):652-61.
112. Nardin JM, Weeks A, Carroli G. Umbilical vein injection for management of retained placenta. Cochrane Database of Systematic Reviews 2011, Issue 5. [DOI: 10.1002/14651858.CD001337]
113. Novikova N, Hofmeyr GJ. Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database of Systematic Reviews 2010, Issue 7. [DOI: 10.1002/14651858.CD007872]
114. O'Brien P, El-Refaey H, Gordon A, Geary M, Rodeck CH. Rectally administered misoprostol for the treatment of postpartum haemorrhage unresponsive to oxytocin and ergometrine: a descriptive study. Obstetrics & Gynecology 1998;92:212-4.
115. Oboro VO, Tabowei TO, Bosah JO. Intrauterine misoprostol for refractory postpartum haemorrhage. International Journal of Gynecology & Obstetrics 2003;80:67-8.
116. Ochoa M, Allaire AD, Stitely ML. Pyometria after hemostatic square suture technique. Obstetrics & Gynecology 2002;99(3):506-9.
117. Ojengbede OA, Morhason-Bello IO, Galadanci H, Meyer C, Nsima D, Camlin C, et al. Assessing the role of the non-pneumatic anti-shock garment in reducing mortality from postpartum hemorrhage in Nigeria. Gynecologic and Obstetric Investigation 2011;71(1):66-72.
118. Oladapo OT, Fawole B, Blum J, Abalos E. Advance misoprostol distribution for preventing and treating postpartum haemorrhage. Cochrane Database of Systematic Reviews 2012, Issue 2. [DOI: 10.1002/14651858.CD009336]
119. Oladapo OT, Okusanya BO, Abalos E. Intramuscular versus intravenous prophylactic oxytocin for the third stage of labour. Cochrane Database of Systematic Reviews 2012, Issue 2. [DOI: 10.1002/14651858.CD009332]
120. Oleen MA, Mariano JP. Controlling refractory atonic postpartum hemorrhage with hemabate sterile solution. American Journal of Obstetrics and Gynecology 1990;162(1):205-8.
121. Ouahba J, Piketty M, Huel C, Azarian M, Feraud O, Luton D, et al. Uterine compression sutures for postpartum bleeding with uterine atony. BJOG: an international journal of obstetrics and gynaecology 2007;114(5):619-22.
122. Peitsidis P, Kadir RA. Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum. Expert Opinion on Pharmacotherapy 2011;12(4):503-16.
123. Penninx JP, Pasmans HL, Oei SG. Arterial balloon occlusion of the internal iliac arteries for treatment of life-threatening massive postpartum haemorrhage: a series of 15 consecutive cases. European Journal of Obstetrics & Gynecology, and Reproductive Biology 2010;148(2):131-4.
124. Pereira A, Nunes F, Pedroso S, Saraiva J, Retto H, Meirinho M. Compressive uterine sutures to treat postpartum bleeding secondary to uterine atony. Obstetrics and Gynecology 2005;106(3):569-72.
125. Porro E. Della amputazione utero-ovarica come complemento di taglio cesareo. Milan 1876.
126. Poujade O, Grossetti A, Mougel L, Ceccaldi P, Ducarme G, Luton D. Risk of synechiae following uterine compression sutures in the management of major postpartum haemorrhage. BJOG: an international journal of obstetrics and gynaecology 2011;118:433-9.
127. Prendiville WJ, Elbourne DR. Care during the third stage of labour. In: Chalmers I, Enkin M, Keirse MJNC editor(s). Effective care in pregnancy and childbirth. Oxford: Oxford University Press, 1989:1145-69.
128. Pritchard JA, Baldwin RM, Dickey JC, Wiggins KM. Blood volume changes in pregnancy and puerperium, II: red blood cell loss and changes in apparent blood volume during and following vaginal delivery, cesarean section, and cesarean section plus total hysterectomy. American Journal of Obstetrics and Gynecology 1962;84:1271-82.
129. Rath W. Prevention of postpartum haemorrhage with the oxytocin analogue carbetocin. European Journal of Obstetrics & Gynecology, and Reproductive Biology 2009;147(1):15-20.
130. Rathat G, Do Trinh P, Mercier G, Reyftmann L, Dechanet C, Boulot P, et al. Synechia after uterine compression sutures. Fertility and Sterility 2011;95(1):405-9.
131. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
132. Ripley DL. Uterine emergencies. Atony, inversion, and rupture. Obstetrics and Gynecology Clinics of North America 1999;26(3):419-34.
133. Sloan NL, Durocher J, Aldrich T, Blum J, Winikoff B. What measured blood loss tells us about postpartum bleeding: a systematic review. BJOG: an international journal of obstetrics and gynaecology 2010;117(7):788-800.
134. Stafford I, Dildy GA, Clark SL, Belfort MA. Visually estimated and calculated blood loss in vaginal and cesarean delivery. American Journal of Obstetrics and Gynecology 2008;199(5):e511-e517.
135. Stearns J. Account of the pulvis parturiens, a remedy for quickening childbirth. Medical Repository of New York 1808;11:308-9.
136. Steans J. Observations on the secale cornutum or ergot, with directions for its use in parturition. Medical Research 1822;5:90.
137. Stoll A, Burckhardt E. L'ergobasine, nouvel alkaloide de l'ergot de seigle, solubile dans l'eau. Bulletin of Pharmaceutical Sciences 1935;42:257-66.
138. Stones RW, Paterson CM, Saunders NSTG. Risk factors for major obstetric haemorrhage. European Journal of Obstetrics & Gynecology and Reproductive Biology 1993;48:15-8.
139. Su LL, Chong YS, Samuel M. Oxytocin agonists for preventing postpartum haemorrhage. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD005457]
140. Su LL, Chong YS, Samue lM. Carbetocin for preventing postpartum haemorrhage. Cochrane Database of Systematic Reviews 2012, Issue 2. [DOI: 10.1002/14651858.CD005457.pub3]
141. Suzuki S, Hiraizumi Y, Miyake H. Risk factors for postpartum hemorrhage requiring transfusion in cesarean deliveries for Japanese twins: comparison with those for singletons. Archives of Gynecology and Obstetrics 2012;286(6):1363-7.
142. Tang OS, Schweer H, Seyberth HW, Lee SW, Ho PC. Pharmacokinetics of different routes of administration of misoprostol. Human Reproduction 2002;17:332-6.
143. Thompson MR. The active constituents of ergot. A pharmacological and chemical study. Journal of the American Pharmaceutical Association 1935;24:185-96.
144. Tseng JJ, Ho JY, Wen MC, Hwang JI. Uterine necrosis associated with acute suppurative myometritis after angiographic selective embolization for refractory postpartum hemorrhage. American Journal of Obstetrics and Gynecology 2011;204(6):e4-e6.
145. Tsu VD. Postpartum haemorrhage in Zimbabwe: a risk factor analysis. British Journal of Obstetrics and Gynaecology 1993;100:327-33.
146. Tunçalp Ö, Hofmeyr GJ, Gülmezoglu AM. Prostaglandins for preventing postpartum haemorrhage. Cochrane Database of Systematic Reviews 2012, Issue 8. [DOI: 10.1002/14651858.CD000494.pub4]
147. Vahedi M, Ayuyao A, Parsa M, Freeman H. Pneumatic antishock garment-associated compartment syndrome in uninjured lower extremities. Journal of Trauma 1995;384(4):616-8.
148. Wetta LA, Szychowski JM, Seals S, Mancuso MS, Biggio JR, Tita AT. Risk factors for uterine atony/postpartum hemorrhage requiring treatment after vaginal delivery. American Journal of Obstetrics and Gynecology 2013;209(1):51.e1-51.e6.
149. WHO, UNICEF, UNFPA. The World Bank World Health Organization (WHO) Press. Trends in Maternal Mortality: 1990 to 2008: Estimates Developed by WHO, UNICEF, UNFPA and The World Bank. Geneva: WHO, 2010.
150. Zheng J, Xiong X, Ma Q, Zhang X, Li M. A new uterine compression suture for postpartum haemorrhage with atony. BJOG: an international journal of obstetrics and gynaecology 2011;118:370-4.
151. Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstetrics & Gynecology 1997;90:88-92.
152. Hofmeyr GJ, Gülmezoglu AM, Novikova N, Linder V, Ferreira S, Piaggio G. Misoprostol to prevent and treat postpartum haemorrhage: a systematic review and meta-analysis of maternal deaths and dose-related effects. Bulletin of the World Health Organization 2009;87(9):666-77.
153. Mousa HA, Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane Database of Systematic Reviews 2003, Issue 1. [DOI: 10.1002/14651858.CD003249]
154. Mousa HA, Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD003249.pub2]